Best Penny Stocks Under 25 Cents Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. These penny stocks all have a super-low share price of $0.25 or less and are sorted by average trading volume in dollars. These companies are considered the most actively-traded stocks priced under $0.25. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Omega Therapeutics NASDAQ:OMGA$0.15 -0.03 (-18.35%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$0.16 +0.01 (+3.25%) As of 07:35 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Omega Therapeutics, Inc operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. More about Omega TherapeuticsMarket Capitalization$10.44 millionConsensus RatingModerate BuyConsensus Price Target$9.20 (+5,874.0% Upside)Volume3.28 million sharesAverage Volume24.93 million sharesToday's Range$0.15▼$0.19 Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. CNS Pharmaceuticals NASDAQ:CNSP$0.07 -0.01 (-11.81%) Closing price 02/20/2025 03:59 PM EasternExtended Trading$0.07 0.00 (-5.14%) As of 02/20/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.CNS Pharmaceuticals, Inc, a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. More about CNS PharmaceuticalsMarket Capitalization$4.82 millionConsensus RatingStrong BuyConsensus Price Target$25.00 (+33,729.5% Upside)Volume36.21 million sharesAverage Volume44.17 million sharesToday's Range$0.07▼$0.093. Windtree Therapeutics NASDAQ:WINT$0.10 -0.01 (-5.23%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$0.10 0.00 (-0.83%) As of 02/20/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Windtree Therapeutics, Inc, a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. More about Windtree TherapeuticsMarket Capitalization$1.12 millionConsensus RatingHoldConsensus Price Target$350.00 (+364,483.3% Upside)Volume5.53 million sharesAverage Volume16.97 million sharesToday's Range$0.09▼$0.104. Aptose Biosciences NASDAQ:APTO$0.19 +0.04 (+26.75%) As of 02/20/2025 04:00 PM EasternAptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. More about Aptose BiosciencesMarket Capitalization$9.64 millionConsensus RatingBuyConsensus Price Target$4.33 (+2,180.7% Upside)Volume181.57 million sharesAverage Volume7.86 million sharesToday's Range$0.18▼$0.265. AEON Biopharma NASDAQ:AEON$0.11 -0.01 (-6.70%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$0.11 0.00 (-1.21%) As of 07:32 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AEON Biopharma, Inc, a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and posttraumatic stress disorder. More about AEON BiopharmaMarket Capitalization$9.20 millionConsensus RatingBuyConsensus Price Target$5.00 (+4,559.8% Upside)Volume5.85 million sharesAverage Volume6.04 million sharesToday's Range$0.10▼$0.116. T2 Biosystems NASDAQ:TTOO$0.23 +0.01 (+2.62%) As of 02/20/2025 03:59 PM EasternT2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. More about T2 BiosystemsMarket Capitalization$4.74 millionConsensus RatingHoldConsensus Price Target$5.00 (+2,064.5% Upside)Volume993,465 sharesAverage Volume2.61 million sharesToday's Range$0.18▼$0.257. Applied DNA Sciences NASDAQ:APDN$0.16 0.00 (-1.22%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$0.16 +0.00 (+0.19%) As of 07:11 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. More about Applied DNA SciencesMarket Capitalization$8.92 millionP/E Ratio-0.03Consensus RatingBuyConsensus Price Target$1.50 (+827.6% Upside)Volume1.54 million sharesAverage Volume3.00 million shares8. Splash Beverage Group NYSEAMERICAN:SBEV$0.17 +0.00 (+1.76%) Closing price 02/20/2025 04:10 PM EasternExtended Trading$0.17 0.00 (0.00%) As of 07:28 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Splash Beverage Group, Inc engages in the manufacturing, distribution, marketing, and sale of various beverages in the United States. More about Splash Beverage GroupMarket Capitalization$10.19 millionConsensus RatingBuyConsensus Price Target$0.75 (+346.4% Upside)Volume1.62 million sharesAverage Volume2.44 million sharesToday's Range$0.16▼$0.179. Zomedica NYSEAMERICAN:ZOM$0.12 +0.00 (+0.25%) Closing price 02/20/2025 04:10 PM EasternExtended Trading$0.12 +0.00 (+0.33%) As of 07:18 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. More about ZomedicaMarket Capitalization$117.89 millionConsensus RatingStrong BuyVolume2.35 million sharesAverage Volume3.27 million sharesToday's Range$0.12▼$0.1250-Day Range$0.00▼$0.0010. P3 Health Partners NASDAQ:PIII$0.22 +0.00 (+1.58%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$0.21 -0.01 (-3.71%) As of 07:15 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. More about P3 Health PartnersMarket Capitalization$77.04 millionConsensus RatingModerate BuyConsensus Price Target$2.38 (+989.0% Upside)Volume1.21 million sharesAverage Volume1.23 million sharesToday's Range$0.20▼$0.2211. AIM ImmunoTech NYSE:AIM$0.14 +0.01 (+6.65%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$0.14 0.00 (-1.26%) As of 02/20/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AIM ImmunoTech Inc, an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. More about AIM ImmunoTechMarket Capitalization$9.21 millionConsensus RatingBuyConsensus Price Target$2.75 (+1,825.8% Upside)Volume684,281 sharesAverage Volume1.61 million sharesToday's Range$0.13▼$0.1512. Syros Pharmaceuticals NASDAQ:SYRS$0.18 0.00 (-2.06%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$0.18 +0.00 (+2.39%) As of 07:22 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Syros Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. More about Syros PharmaceuticalsMarket Capitalization$4.82 millionConsensus RatingHoldConsensus Price Target$3.33 (+1,796.1% Upside)Volume623,294 sharesAverage Volume1.14 million sharesToday's Range$0.17▼$0.1813. Bio-Path NASDAQ:BPTH$0.20 +0.07 (+51.29%) As of 02/20/2025 03:59 PM EasternBio-Path Holdings, Inc operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. More about Bio-PathMarket Capitalization$760 thousandConsensus RatingBuyConsensus Price Target$20.00 (+9,900.0% Upside)Volume1.06 million sharesAverage Volume953,990 sharesToday's Range$0.13▼$0.2114. Lyra Therapeutics NASDAQ:LYRA$0.20 +0.00 (+0.10%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$0.20 +0.01 (+3.24%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lyra Therapeutics, Inc, a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. More about Lyra TherapeuticsMarket Capitalization$12.92 millionConsensus RatingHoldConsensus Price Target$4.50 (+2,177.3% Upside)Volume905,342 sharesAverage Volume850,430 sharesToday's Range$0.19▼$0.2015. Aspira Women's Health NASDAQ:AWH$0.23 -0.01 (-5.50%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$0.23 +0.00 (+1.32%) As of 02/20/2025 04:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aspira Women's Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. More about Aspira Women's HealthMarket Capitalization$4.25 millionConsensus RatingModerate BuyConsensus Price Target$4.40 (+1,838.3% Upside)Volume178,378 sharesAverage Volume284,404 sharesToday's Range$0.23▼$0.2516. MariMed OTCMKTS:MRMD$0.13 0.00 (-2.58%) As of 02/20/2025 03:58 PM EasternMariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. More about MariMedMarket Capitalization$50.36 millionP/E Ratio-3.30Consensus RatingStrong BuyVolume595,449 sharesAverage Volume389,895 sharesToday's Range$0.13▼$0.1417. Cannabist OTCMKTS:CBSTF$0.06 +0.00 (+6.83%) As of 02/20/2025 03:38 PM EasternThe Cannabist Company Holdings Inc engages in the cultivation, development, production, home delivery, and dispensary of cannabis products in the United States and internationally. More about CannabistConsensus RatingModerate BuyConsensus Price Target$0.75 (+1,232.1% Upside)Volume216,370 sharesAverage Volume842,317 sharesToday's Range$0.05▼$0.0650-Day Range$0.05▼$0.0818. Viracta Therapeutics NASDAQ:VIRX$0.03 -0.01 (-20.05%) As of 02/20/2025 03:56 PM EasternViracta Therapeutics, Inc, a clinical-stage precision oncology company, focuses on the treatment and prevention of virus-associated cancers that impact patients worldwide. More about Viracta TherapeuticsMarket Capitalization$1.47 millionConsensus RatingModerate BuyConsensus Price Target$4.05 (+13,628.8% Upside)Volume573,215 sharesAverage Volume1.61 million sharesToday's Range$0.02▼$0.0419. BIOLASE NASDAQ:BIOL$0.0095 0.00 (0.00%) As of 02/19/2025BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. More about BIOLASEMarket Capitalization$316 thousandP/E Ratio0.00Consensus RatingModerate BuyConsensus Price Target$1.20 (+12,598.4% Upside)Volume43,268 sharesAverage Volume2.58 million shares20. Exro Technologies OTCMKTS:EXROF$0.07 +0.00 (+1.05%) As of 02/20/2025 03:50 PM EasternExro Technologies Inc focuses on developing generation power-control electronics in Canada. The company offers Exro Coil Driver, which allows the motor to switch between different operational profiles in real-time, as well as have multiple gears for scooters, electric bikes, recreational, light electric cars, motorcycles, fleet vans, electric buses, passenger vehicles, long-haul trucks, and industrial vehicles markets; and Exro Cell Driver, a stationary energy storage system for commercial and industrial energy storage applications. More about Exro TechnologiesMarket Capitalization$36.54 millionConsensus RatingHoldVolume83,010 sharesAverage Volume273,968 sharesToday's Range$0.07▼$0.0850-Day Range$0.06▼$0.1121. LuxUrban Hotels NASDAQ:LUXH$0.06 0.00 (-0.31%) As of 02/20/2025 03:50 PM EasternLuxUrban Hotels Inc utilizes an asset light business model to lease entire hotels on a long-term basis and rent out hotel rooms in the properties it leases. More about LuxUrban HotelsMarket Capitalization$180 thousandConsensus RatingHoldConsensus Price Target$280.00 (+431,998.8% Upside)Volume46,827 sharesAverage Volume278,476 sharesToday's Range$0.06▼$0.0722. The Container Store Group NYSE:TCS$0.14 0.00 (0.00%) As of 02/19/2025The Container Store Group, Inc operates as a specialty retailer of organizing solutions, custom spaces, and in-home organizing services in the United States. More about The Container Store GroupMarket Capitalization$9.15 millionP/E Ratio0.00Consensus RatingHoldConsensus Price Target$1.00 (+611.9% Upside)Average Volume83,852 sharesToday's Range$0.14▼$0.1423. Nextech3D.AI OTCMKTS:NEXCF$0.04 0.00 (-2.24%) As of 02/20/2025 03:54 PM EasternNextech3D.AI Corporation provides augmented reality technologies, wayfinding technologies, and 3D model services. It focuses on creating 3D WebAR photorealistic models for the prime ecommerce marketplace, as well as other online retailers. More about Nextech3D.AIMarket Capitalization$5.76 millionConsensus RatingBuyConsensus Price Target$0.25 (+537.8% Upside)Volume235,873 sharesAverage Volume292,534 sharesToday's Range$0.04▼$0.0424. Biora Therapeutics NASDAQ:BIOR$0.13 0.00 (0.00%) As of 02/19/2025Biora Therapeutics, Inc, a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. More about Biora TherapeuticsMarket Capitalization$588 thousandP/E Ratio-0.01Consensus RatingBuyConsensus Price Target$23.00 (+17,592.3% Upside)Volume23,714 sharesAverage Volume58,319 shares25. Loop Media NYSEAMERICAN:LPTV$0.04 0.00 (-2.15%) As of 02/20/2025 03:44 PM EasternLoop Media, Inc operates as a multichannel digital video platform media company in the United States. The company offers hand-curated music video content licensed from major and independent record labels, including Universal Music Group, Sony Music Entertainment, and Warner Music Group; and non-music video content, which is licensed or acquired from third parties, such as action sports clips, drone and atmospheric footage, trivia, news headlines, lifestyle channels, and kid-friendly videos, as well as movie, television and video game trailers, and other content. More about Loop MediaMarket Capitalization$3.48 millionConsensus RatingBuyConsensus Price Target$1.00 (+2,339.0% Upside)Volume60,374 sharesAverage Volume151,137 sharesToday's Range$0.04▼$0.04 More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive SoundHound AI Stock at a Crossroads—Is a Bottom in Sight? SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It? Buffett’s Billion-Dollar Bet: Will Constellation Brands Pay Off? 3 Stocks With Robust Growth Outlooks Insiders Are Buying Buffett Just Dumped His S&P 500 Holdings—What It Means for You Up Nearly 1000%, Can AppLovin Keep Delivering for Investors? Hims & Hers Earnings Could Be a Game Changer—What to Do Now Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
